|Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases|
H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ...
Cancer research 59 (22), 5830-5835, 1999
|Identification of a chromosome 18q gene that is altered in colorectal cancers|
ER Fearon, KR Cho, JM Nigro, SE Kern, JW Simons, JM Ruppert, ...
Science 247 (4938), 49-56, 1990
|Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells …|
H Zhong, K Chiles, D Feldser, E Laughner, C Hanrahan, MM Georgescu, ...
Cancer research 60 (6), 1541-1545, 2000
|In vivo molecular and cellular imaging with quantum dots|
X Gao, L Yang, JA Petros, FF Marshall, JW Simons, S Nie
Current opinion in biotechnology 16 (1), 63-72, 2005
|Nanotechnology applications in cancer|
S Nie, Y Xing, GJ Kim, JW Simons
Annu. Rev. Biomed. Eng. 9, 257-288, 2007
|The genomic complexity of primary human prostate cancer|
MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ...
Nature 470 (7333), 214-220, 2011
|Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response|
ER Fearon, DM Pardoll, T Itaya, P Golumbek, HI Levitsky, JW Simons, ...
Cell 60 (3), 397-403, 1990
|Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group|
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...
Journal of Clinical Oncology 17 (11), 3461-3467, 1999
|Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene|
A Fazeli, SL Dickinson, ML Hermiston, RV Tighe, RG Steen, CG Small, ...
Nature 386 (6627), 796-804, 1997
|2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF|
NJ Mabjeesh, D Escuin, TM LaVallee, VS Pribluda, GM Swartz, ...
Cancer cell 3 (4), 363-375, 2003
|Levels of hypoxia-inducible factor-1α during breast carcinogenesis|
R Bos, H Zhong, CF Hanrahan, ECM Mommers, GL Semenza, HM Pinedo, ...
Journal of the national cancer institute 93 (4), 309-314, 2001
|Expression of hypoxia‐inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression|
D Zagzag, H Zhong, JM Scalzitti, E Laughner, JW Simons, GL Semenza
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
|Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells|
R Rodriguez, ER Schuur, HY Lim, GA Henderson, JW Simons, ...
Cancer research 57 (13), 2559-2563, 1997
|Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate|
JB Nelson, SP Hedican, DJ George, AH Reddi, S Piantadosi, ...
Nature medicine 1 (9), 944-949, 1995
|Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry|
Y Xing, Q Chaudry, C Shen, KY Kong, HE Zhau, LW Chung, JA Petros, ...
Nature protocols 2 (5), 1152-1165, 2007
|Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia|
H Zhong, JW Simons
Biochemical and biophysical research communications 259 (3), 523-526, 1999
|Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte …|
JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ...
Cancer research 59 (20), 5160-5168, 1999
|Tracking the clonal origin of lethal prostate cancer|
MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ...
The Journal of clinical investigation 123 (11), 4918-4922, 2013
|Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by ex Vivo Granulocyte-Macrophage Colony-stimulating Factor Gene Transfer|
JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ...
Cancer research 57 (8), 1537-1546, 1997
|A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy|
TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ...
Cancer research 61 (20), 7464-7472, 2001